文献速递泌尿生殖与妇科肿瘤放疗姑息放疗与转移瘤

接受根治性放化疗的妇科癌症女性患者报告结局:一项前瞻性临床试验

Patient Reported Outcomes for Women Undergoing Definitive Chemoradiation for Gynecologic Cancer: A Prospective Clinical Trial.
PubMed 文献 · Pract Radiat Oncol · 2023-08-18

基线总体健康状况差于参考人群(41 vs 59,P<.001),随访时进一步下降(42 vs 33,P=.005);与宫颈癌参考值相比,社会功能、经济毒性、疲劳、恶心呕吐、食欲丧失均更差。作者认为该高风险人群症状与心理社会毒性负担重,需改善治疗全程支持。

要点

  • 33例入组、29例(88%)完成基线患者报告结局评估。
  • 基线总体健康状况41 vs 参考人群59(P<.001),随访时42 vs 33(P=.005)。
  • 多数患者报告抑郁53%、自觉吸引力下降64%、生活受干扰66%和担忧69%。

核心结论

  • 宫颈癌患者症状负担和心理社会毒性显著,导致生活质量下降,作者认为需改善该高风险人群治疗全程的支持。

研究设计与样本

  • 单机构前瞻性试验,评估接受近距离放疗的妇科癌症患者结局,共入组33例,29例(88%)完成基线患者报告结局评估。
  • 功能量表和总体健康状况评分越高越好,症状条目评分越低越好;QLQ-C30平均分与参考人群比较,研究人群不同时间点比较采用中位数、四分位距和非参数检验。

主要发现

  • 基线平均总体健康评分差于任何癌症诊断女性参考人群(41 vs 59,P<.001),随访时进一步下降(42 vs 33,P=.005)。
  • 与宫颈癌参考值相比,本研究患者社会功能(62 vs 83,P=.03)、经济毒性(49 vs 10,P<.001)、疲劳(49 vs 34,P=.04)、恶心呕吐(26 vs 9,P=.001)和食欲丧失(36 vs 16,P=.004)均显著更差。
  • 多数患者报告抑郁(53%)、自觉吸引力下降(64%)、生活受干扰(66%)和/或担忧(69%)。
  • 基线时较高总体健康评分与较好躯体功能(R²0.58,P<.001)、社会功能(R²0.56,P<.001)和体像(R²0.40,P<.001)相关;较低评分与更多症状负担(R²0.71,P<.001)、经济毒性(R²0.50,P<.001)和/或性担忧(R²0.25,P=.001)相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Patients with gynecologic malignancies have high psychosocial and symptom burden. We report data from a prospective trial evaluating patient-reported outcome (PRO) metrics in women undergoing definitive chemoradiation with brachytherapy (BT). METHODS AND MATERIALS: A single-institution prospective trial evaluating outcomes of gynecologic cancer patients undergoing BT. Questionnaires to assess PROs at baseline, post-BT, and 60-day follow-up were collected, using European Organization for Research and Treatment of Cancer-Quality of Life Question-Core 30 and European Organization for Research and Treatment of Cancer-Quality of Life Question-Cervical Cancer Module validated metrics. Higher scores for functional scales/global health and lower scores for symptom items are favorable. European Organization for Research and Treatment of Cancer-Quality of Life Question-Core 30 mean scores were compared with a reference population. When comparing the study population between time points, medians, interquartile range, and nonparametric testing were used. RESULTS: Thirty-three patients were enrolled, and 29 (88%) completed baseline PRO metrics. Mean global health score was worse than the reference population of women with any cancer diagnosis at baseline (41 vs 59, P < .001) and decreased further at follow-up (42 vs 33, P = .005). Compared with the cervical cancer reference, our patients had significantly worse social function (62 vs 83, P = .03), financial toxicity (49 vs 10, P < .001), fatigue (49 vs 34, P = .04), nausea/vomiting (26 vs 9, P = .001), and appetite loss (36 vs 16, P = .004).The majority of patients described depression (53%), feeling less attractive (64%), life interference (66%), and/or worry (69%). At baseline, higher global health scores were associated with improved physical functioning (R20.58, P < .001), social functioning (R20.56, P < .001), and body image (R20.40, P < .001); lower scores with more symptom burden (R20.71, P < .001), financial toxicity (R20.50, P < .001), and/or sexual worry (R20.25, P = .001). CONCLUSIONS: Patients with cervical cancer have significant symptom burden and psychosocial toxicity, contributing to decreased quality of life. These data highlight the need for improved support throughout treatment for this high-risk population.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Andring LM, Corrigan KL, Rooney M, et al. Patient Reported Outcomes for Women Undergoing Definitive Chemoradiation for Gynecologic Cancer: A Prospective Clinical Trial. Pract Radiat Oncol. 2023. PMID: 37597615. doi:10.1016/j.prro.2023.07.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。